Heralded Two-Photon Entanglement from Probabilistic Quantum Logic Operations on Multiple Parametric Down-Conversion Sources

An ideal controlled-NOT gate followed by projective measurements can be used to identify specific Bell states of its two input qubits. When the input qubits are each members of independent Bell states, these projective measurements can be used to swap the post-selected entanglement onto the remaining two qubits. Here we apply this strategy to produce heralded two-photon polarization entanglement using Bell states that originate from independent parametric down-conversion sources, and a particular probabilistic controlled-NOT gate that is constructed from linear optical elements. The resulting implementation is closely related to an earlier proposal by Sliwa and Banaszek [quant-ph/0207117], and can be intuitively understood in terms of familiar quantum information protocols. The possibility of producing a ``pseudo-demand'' source of two-photon entanglement by storing and releasing these heralded pairs from independent cyclical quantum memory devices is also discussed.Comment: 5 pages, 4 figures; submitted to IEEE Journal of Selected Topics in Quantum Electronics, special issue on "Quantum Internet Technologies

Generation of entangled ancilla states for use in linear optics quantum computing

We describe several different methods for generating the entangled ancilla states that are required for linear optics quantum computing. We show that post-selection can be used in combination with linear optical elements to generate the entangled ancilla, but with an exponentially-small efficiency. Alternatively, the ancilla can be efficiently generated using solid-state devices consisting of quantum wells coupled with tunnel junctions. Finally, we consider the possibility of using encoded ancilla in order to reduce the effects of decoherence and measurement errors.Comment: 23 pages, 10 figure

Diameter-controlled solid-phase seeding of germanium nanowires: structural characterization and electrical transport properties

Despite the huge progress recently made in understanding the phenomena of metal-promoted growth of one-dimensional (1D) semiconductors, the controlled formation of small diameter semiconductor nanowires is still challenging. Liquid growth promoters, such as the low melting Au/Ge eutectic, allow control of the aspect ratio, diameter, and structure of 1D crystals via external parameters, such as precursor feedstock, temperature, and operating pressure. However, the incorporation of metal atoms during the growth process, size variations of the nanowires due to agglomeration of the nucleating metal seeds, and surface diffusion of Au via the vapor–liquid–solid route have been reported. Here, we detail the influence of solid growth seeds, such as NiGe2 formed from Ni nanoparticles, on the lateral dimensions of Ge nanowires grown using a supercritical fluid growth process. Beneficial control over the mean nanowire diameter, in the sub-20 nm regime, with a predominantly ⟨110⟩ growth direction and low structural defect concentration was obtained using Ni seeds. In addition, the effect of prealloying of Ni–Fe films for the growth of Ge nanowires was investigated, which leads to a bimodal nanowire distribution. Electrical characterization performed on single nanowire devices showed p-type behavior for Ge nanowires grown from Ni and Ni/Fe seeds. Determination of resistivities, majority carrier concentrations, and mobilities suggest significant doping of the Ge nanowires by Ni when grown via a supercritical fluid–solid–solid (SFSS) mechanism

What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review

© 2014 Sullivan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Introduction: Network meta-analyses (NMAs) are complex methodological approaches that may be challenging for non-technical end-users, such as policymakers and clinicians, to understand. Consideration should be given to identifying optimal approaches to presenting NMAs that help clarify analyses. It is unclear what guidance researchers currently have on how to present and tailor NMAs to different end-users. Methods: A systematic review of NMA guidelines was conducted to identify guidance on how to present NMAs. Electronic databases and supplementary sources were searched for NMA guidelines. Presentation format details related to sample formats, target audiences, data sources, analysis methods and results were extracted and frequencies tabulated. Guideline quality was assessed following criteria developed for clinical practice guidelines. Results: Seven guidelines were included. Current guidelines focus on how to conduct NMAs but provide limited guidance to researchers on how to best present analyses to different end-users. None of the guidelines provided reporting templates. Few guidelines provided advice on tailoring presentations to different end-users, such as policymakers. Available guidance on presentation formats focused on evidence networks, characteristics of individual trials, comparisons between direct and indirect estimates and assumptions of heterogeneity and/or inconsistency. Some guidelines also provided examples of figures and tables that could be used to present information. Conclusions: Limited guidance exists for researchers on how best to present NMAs in an accessible format, especially for non-technical end-users such as policymakers and clinicians. NMA guidelines may require further integration with end-users' needs, when NMAs are used to support healthcare policy and practice decisions. Developing presentation formats that enhance understanding and accessibility of NMAs could also enhance the transparency and legitimacy of decisions informed by NMAs.The Canadian Institute of Health Research (CIHR) Drug Safety and Effectiveness Network (Funding reference number – 116573)

Rhythm and Vowel Quality in Accents of English

In a sample of 27 speakers of Scottish Standard English two notoriously variable consonantal features are investigated: the contrast of /m/ and /w/ and non-prevocalic /r/, the latter both in terms of its presence or absence and the phonetic form it takes, if present. The pattern of realisation of non-prevocalic /r/ largely confirms previously reported findings. But there are a number of surprising results regarding the merger of /m/ and /w/ and the loss of non-prevocalic /r/: While the former is more likely to happen in younger speakers and females, the latter seems more likely in older speakers and males. This is suggestive of change in progress leading to a loss of the /m/ - /w/ contrast, while the variation found in non-prevocalic /r/ follows an almost inverse sociolinguistic pattern that does not suggest any such change and is additionally largely explicable in language-internal terms. One phenomenon requiring further investigation is the curious effect direct contact with Southern English accents seems to have on non-prevocalic /r/: innovation on the structural level (i.e. loss) and conservatism on the realisational level (i.e. increased incidence of [r] and [r]) appear to be conditioned by the same sociolinguistic factors

Using individual participant data to improve network meta-analysis projects.

A network meta-analysis combines the evidence from existing randomised trials about the comparative efficacy of multiple treatments. It allows direct and indirect evidence about each comparison to be included in the same analysis, and provides a coherent framework to compare and rank treatments. A traditional network meta-analysis uses aggregate data (eg, treatment effect estimates and standard errors) obtained from publications or trial investigators. An alternative approach is to obtain, check, harmonise and meta-analyse the individual participant data (IPD) from each trial. In this article, we describe potential advantages of IPD for network meta-analysis projects, emphasising five key benefits: (1) improving the quality and scope of information available for inclusion in the meta-analysis, (2) examining and plotting distributions of covariates across trials (eg, for potential effect modifiers), (3) standardising and improving the analysis of each trial, (4) adjusting for prognostic factors to allow a network meta-analysis of conditional treatment effects and (5) including treatment-covariate interactions (effect modifiers) to allow relative treatment effects to vary by participant-level covariate values (eg, age, baseline depression score). A running theme of all these benefits is that they help examine and reduce heterogeneity (differences in the true treatment effect between trials) and inconsistency (differences in the true treatment effect between direct and indirect evidence) in the network. As a consequence, an IPD network meta-analysis has the potential for more precise, reliable and informative results for clinical practice and even allows treatment comparisons to be made for individual patients and targeted populations conditional on their particular characteristics